U.S. Steps Up Effort Against Drug Imports

Article Abstract:

The FDA, in coordination with the US Customs Bureau, is investigating drugs that are coming from Canada at substantially cheaper prices than those of US products. The agencies maintain that the pharmaceuticals are defective because they are produced in other countries and are counterfeit copies of US drugs. States and cities that support the imports maintain that the FDA has not shown that anyone has been harmed by the imports. They believe that the Canadian drugs help save money for public employees. The pharmaceutical industry depends on much of its profit from US sales of drugs at higher prices and wants the FDA to uphold legislation that prevents imports unless they are safe.

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Government domestic functions, Financial management, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Drugs, Metabolic Agents NEC, Metabolic Agents, Finance, Social policy, Company financing, United States. Customs and Border Protection, McClellan, Mark

---

Drug Makers' New Intensity In Defense of U.S. Borders

Article Abstract:

Pharmaceutical manufacturers are campaigning hard against any congressional legislation that would allow both wholesale and Internet imports of their drugs that are priced more cheaply overseas and in Canada. American consumers are able to reduce their prescription costs by purchasing their medications outside of the US. Drug companies are concerned about the threat to profits which in turn could hurt research and development for new drugs. They also fear safety factors that may be diminished if any business entity can ship drugs to the US.

Europe, Government regulation (cont), Government expenditures, Government regulation, Public affairs, Legislative Bodies, Legal/Government Regulation, US House of Representatives, US Senate, Laws, regulations and rules, Political activity, Economic policy, United States. Congress. Senate, United States. Congress. House

---

Pfizer Moves to Stem Canadian Drug Imports

Article Abstract:

Pfizer Inc. has joined other US pharmaceutical companies, such as GlaxoSmithKline, Wyeth and AstraZeneca, in tracking orders from Canadian pharmacies to see that they do not exceed prescriptions from Canadian doctors. Despite House passage of a bill allowing drug imports into the US from Canadian pharmacies, manufacturers are threatening to withhold shipments to them to prevent drugstore exports to US customers who have to pay 67% more for drugs.

Drug stores and proprietary stores, Pharmacies and Drug Stores, Drug Stores, Exports, Cases, Pfizer Inc., Drugstores, PFE

Similar abstracts:

• Abstracts: Suzy Shier's fake bargains bring $1-million dressing down. La Senza says yes to U.S. suitor. La Senza selling Suzy Shier chain
• Abstracts: U.S. files suit against RxDepot. Can he win the patent game? Mine chief fights mob rumours
• Abstracts: MacDonald Mines makes bid for Bresea. TD makes move into charity foundation business
• Abstracts: OMERS selling part of mall portfolio into investment trust. Brookfield group sweetens bid for O&Y's office portfolio
• Abstracts: Fighting the Idea That All the Internet Is Free. Keeping Moviegoers Away From the Dark Side. Digital (Fill in the Blank) Is on the Horizon

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.